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Bayesian Model Averaging:- An Application
in Cancer Clinical Trial
Atanu Bhattacharjee
Abstract
Data driven conclusion is mostly accepted approach in any medical research prob-
lem. In case of limited knowledge of deep idea about supportive data on the prob-
lem, automatic digging of the variable plays important role for insight view of
the study. Bayesian model averaging can be considered for automatics variable
selection. It can be used as an alternative of stepwise regression method. The
aim of this paper is to show the application of Bayesian modeling averaging in
medical research particularly in cancer trial. Method is illustrated on Bone mar-
row transplant data. It can be recommended that BMA can be used frequently in
data selection and as a tool of exploratory data analysis method. It is very handy
method of choice for data analysis.
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Bayesian Model Averaging:- An Application in Cancer Clinical Trial 
In case of limited subject matter information, automatic variable selection is 
useful to explore relation between outcome and covariates. Although, logistic regression 
and stepwise selection are general approach to be considered to explored the relation 
between outcome and covariates. But it is tedious and time consuming. But the resulting 
estimates is depends on the choice of the selected model. The particular selected model 
can leads to the significance or insignificance test result. In addition, selected regression 
model do not show the uncertainty about choice of the assumed model in the Statistical 
Interpretation. 
Bayesian methods in clinical trial and in medical research have become pretty 
well-known in last ten years due to flexible application, easy interpretation, good 
operative features.  Bayesian is more useful in longitudinal, survival and clinical drug 
treatment comparison. It is performed quite well in adaptive trial design. 
In model selection it can also be useful and can be choice as automatic model 
selection. Bayesian Modeling Averaging (BMA)  givs the lack of confidence in a 
canonical regression. Let y be the dependents variable,  a constant, , the coefficients, 
and  a normal IID having variance . 
   	 
 	 , ~0, .        (1) 
Based on primary end point of the study it is easy to define Y. But among several
, it is not 
possible to select best X. The problem in variable selection is X not Y. 
http://biostats.bepress.com/cobra/art106
3 
 
BMA attempts the problem through estimating the models among all probable combination of 

 and gives the information about weighted average of all of them. Let X is represented as 

, 
, 
and  
. Then possible models are 2  16. 
In experimental study, K numbers of variables may be considered. The number of possible 
model would be 2 . But, selection of best model among 2 models is very difficult. BA with 
weighted average solve the problem. 
Modeling 
Let the Model  , prefers the covariates 
. Then by Bayes theorem it 
can be presented as 
/, 
 
!"#/$%&!$%
!#/'
=
("#/$%,'&!$%
∑ ("#/$%,'&!$%*
+
,-.
      (2) 
Now, the likelihood of /
  for the particular data set will not change. Then it 
can be stated that 0"/ , 
& is the proportional to the marginal likelihood of 0"/
, 
 time prior probability . The term 0"/, 
& is the posterior model 
probability of the data given model. 
Let the coefficient() in equation (1) is estimated by 1 . Then  
1/2, 
  ∑ "1/, , 
&"/
, &
+
34 .         (3) 
Here, s is the possible set of all models. The prior probability models i.e.  5 1 to gives the 
minimum effect of knowledge. 
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Acceptance of BMA 
In classical approach,   0.05 is well accepted principle in the scientific 
community. BMA can be used in this manner. A 95% threshold value can be applied for 
posterior estimation. In this stydy, 95% posterior threshold is used for selecting best 
predictor. The analysis is performed to compare the performance of linear regression 
selection step and BMA. The well-know and widely, applied method in stepwise 
regression is found poorly performed in the theory and case –studies [ Raftery  et al., 
1997 and  Malek et al.,2007]. 
Data Methodology 
The graft dataset comes from a non-depleted allogeneic bone marrow transplant 
from an HLA-identical sibling donor for a haematological malignancy of 37 patients in 
GvHD trial. Information was recorded on recipient age, donor age, type of leukemia and 
status of pregnancy. The aim of the work by Bagot et al,. [1988] was to detect the 
donor/recipient pairs at high risk of GvHD who might benefit of bone marrow T-cell 
depletion. The basic characteristics of the data are provided into the Table 1 and Table 
respectively.  
 
Bayesian Model 
Bayesian methodology in statistical Inference is well-documented [Gelman et a., 
2004, Carlin and Louis 2008 and Ibrahim et al., 2001].  Bayesian differs from the 
classical in terms f uncertainty of the unknown parameter in a model is expressed through 
an entire distribution called the prior distribution. The term “prior” expressed the 
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uncertainty of the parameters before collecting the data in the study. The main inferential 
tool is possible through posterior distribution by application of Bayes Theorem. If 71 
be the prior information about parameter .  89:;:/1 is the likelihood function of the 
data given the parameter . Then 7/9:;:∞89:;:/7 is posterior distribution 
of parameter. The major consideration in the Bayesian is the selection of prior. Priors that 
have a minimal influence on the overall Bayesian analysis are called non-informative 
prior. Flat, Vague, reference-priors are synonyms of the non-informatrive prior. The 
result obtained through non-informative prior is very much similar with classical 
approach. The non-informative prior is relatively “flat” towards distribution of the data. 
Bayesian con be computed in WinBugs, SAS and R. These software packages are 
very powerful for data analysis. Markov Chain Monte Carlo(MCMC) is only required to 
performed to obtain the  Bayesian results. Softwares are now a day’s compatible  for 
Bayesian computation. MCMC is basically simulation based approach to draw sample 
from the posterior distribution of  and have already established as powerful tool for 
even complex model. Dealing with Complex model is really infeasible for classical 
method.  
 Illustration of BMA 
The ‘graft data’ data set describe above having 8 variables named with 
“gvhd“,“index”, “dead”,“preg”, “rcpage “,“time“,“type“ and “donage “respectively. The 
“rcpage” is considered as outcome of interest and rest all are covariates. Now, as stated 
earlier a total of 28 types of model can be formed. Here, BMS library in R software is 
used. R is open source software and can be downloaded from www.cran-project.org. In 
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the bms function, prior is defined as “uniform”. The results obtained through bms 
function on response variables are listed in Table 3. 
In the above results, post mean provides the information about averaged over all 
model in particular coefficient. It shows that variable “gvhd” has the highest coefficient 
value in comparison to others. The posterior inclusion criterion gives the importance of 
the variable in the data. It can be noted that the PIP value and post mean are positively 
correlated. Only “gvhd” can be considered as an important variable in comparison to 
others. The posterior standard deviation gives more information: “gvhd” is positively 
influencing to the on response , but “rcpage” worked as negatively. The column named 
with “Index” gives the indices value of the variable in the data set.  
Modeling  
The posterior model size can be obtained by sum of all PIP. In this example, it 
comes around 3.60.As stated earlier, MCMC is useful for simulation techniques. The 
correlation between analytical observation of PMP and iteration is given in figure1. It 
shows that correlation between iteration and analytical observation are in decent level.A 
total of 2000 models are genereated. The best filled 50 models are given in figure 2.The 
relative performance for consideration of uniform, Fixed, PIP and random prior are given 
in Figure2.    
Discussion 
There are several procedures to detect the best fitted models. The procedures are 
Bayesian Information Criteria (BIC)[ Neath and Cavanaugh (2012)], Decision 
Information Criteria [Spiegelhalter et al., (2002)] and Akkai Information 
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Criteria[Burnham et al. (2002)]. However, the application of those approaches only 
becomes useful when parameters are selected. In case of presence of crude or unselected 
parameters, none of the approach can be performed well. The application of BMA is very 
simple. The open source software R can be used to perform the BMA[Ref]. More detailed 
application of BMA through R are recently discussed [Clyde (2010), Raftery et al. 
(2010a) and Feldkircher and Zeugner (2011)]. 
 
Conclusion 
The BMA is useful to explore the prior information about the prior distribution of 
the parameter of interest. It is useful to specify the parameters to be considered in model 
development stage. The stabilize prediction can only be obtained through application of 
BMA.  An application of BMA on “graft data” set is presented.  The Bayesian analysis 
on graft data is applied for the model illustration. It is suggested to specify about BMA in 
the protocol itself to develop the track for further model development in study design.  
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Table1: graft dataset summary of continuous variable  
Parameters Mean sd Parameters Mean Sd 
Rcpage 25.43 7.50 Donage 25.81 7.83 
Time 669.8 483.71 Index 2.55 2.22 
 
Table2: graft dataset summary of categorical variable  
Parameters Status Freq(%) Parameters Status Freq(%) 
Donor 
Pregnancy 
Status 
Yes 10(27.02%) Type Acute myoloid 
leukarmia(AML) 
11(29.72%) 
No 27(72.98%) Acute 
lymphocytic 
leukarmia(ALL) 
16(43.24%) 
Dead Yes 19(51.35%) 
 No 18 (48.64) Chronic myeloid 
leukarmia(CML) 
10(27.02%) 
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Table 3:- The coefficient table covariates on response variable. 
Parameters              PIP      Post Mean       Post SD  Cond.Pos.Sign Index 
gvhd       1.0000000  12.9443355327  1.5636948959     1.0000000    6 
index   0.9999999   2.2755190644  0.3000631051     1.0000000    5 
dead    0.4607726  -1.0737612621 1.4614983330 0.0000000 8 
preg    0.4302314   1.0833786240  1.5705677172     1.0000000    4 
rcpage  0.2063585   0.0173867110  0.0541033943     1.0000000    1 
time    0.1992714   0.0002177483  0.0009393523     0.8183941    7 
type    0.1549690   0.0106012518  0.3709706438     0.4850185  3 
donage  0.1504394 -0.0039444487 0.0358654882 0.1477814 2 
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Figure1:- The correlation between PMP and iterations.
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Figure2:- The best fitted models 
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